Smith & Nephew Pays $240M For Integra’s Extremities Business
Integra is divesting its underperforming extremity orthopedics product portfolio to focus on its neurosurgery, surgical instrument and regenerative medicine businesses.
You may also be interested in...
Medtech Insight's Deal Making column is a survey of recent health care transactions listed by relevant industry segment – in vitro diagnostics and medical devices – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in January 2022. Data provided by Biomedtracker.
J&J, Smith & Nephew, Stryker, Zimmer Biomet and other companies in the orthopedic and spine surgery space have welcomed a recent rebound in orthopedic device demand, but the volume of elective knee surgeries is still behind its pre-pandemic level.
The resurgence of the pandemic during the fourth quarter of 2020 led to slowdown in elective procedures, negatively impacting sales of the four big ortho players.